Back

Single-Cell Transcriptomic Analysis of Livers During NLRP3 Inflammasome Activation Reveals a Novel Immune Niche

Calcagno, D. M.; Chu, A.; Gaul, S.; Taghdiri, N.; Toomu, A.; Leszczynska, A.; Kaufmann, B.; Wree, A.; Geisler, L.; Hoffman, H. M.; Feldstein, A. E.; King, K. R.

2021-03-31 immunology
10.1101/2021.03.31.437725 bioRxiv
Show abstract

The NOD-like receptor protein 3 (NLRP3) inflammasome is a central contributor to human acute and chronic liver disease, yet the molecular and cellular mechanisms by which its activation precipitates injury remain incompletely understood. Here, we present single cell transcriptomic profiling of livers from a global transgenic Tamoxifen-inducible constitutively-activated Nlrp3A350V mutant mouse, and we investigate the changes in parenchymal and non-parenchymal liver cell gene expression that accompany inflammation and fibrosis. Our results demonstrate that NLRP3 activation causes chronic extramedullary myelopoiesis marked by an increase in proliferating myeloid progenitors that differentiate into neutrophils, monocytes, and monocyte-derived macrophages, results that were corroborated by flow cytometry and histological staining. We observed prominent neutrophil infiltrates with increased Ly6gHI and Ly6gINT cells exhibiting transcriptomic signatures of granulopoiesis typically found in the bone marrow. This was accompanied by a marked increase in Ly6cHI monocytes differentiating into Cd11bHITim4HIClec4fHI macrophages that express proinflammatory transcriptional programs similar to macrophages of non-alcoholic steatohepatitis (NASH) models. NLRP3 activation also downregulated metabolic pathways in hepatocytes and shifted hepatic stellate cells towards an activated pro-fibrotic state based on expression of collagen and extracellular matrix (ECM) regulatory genes. These results, which highlight abundant neutrophils and extramedullary granulopoiesis define an inflamed and fibrotic hepatic single cell microenvironment, precipitated solely by NLRP3 activation. Clinically, our data support the notion that neutrophils and NLRP3 should be explored as therapeutic targets in NASH-like inflammation.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Journal of Hepatology
18 papers in training set
Top 0.1%
19.4%
2
Gastroenterology
40 papers in training set
Top 0.2%
10.1%
3
Hepatology
18 papers in training set
Top 0.1%
8.4%
4
Gut
36 papers in training set
Top 0.1%
6.8%
5
Cellular and Molecular Gastroenterology and Hepatology
41 papers in training set
Top 0.1%
6.4%
50% of probability mass above
6
JCI Insight
241 papers in training set
Top 1%
3.9%
7
Cell Reports
1338 papers in training set
Top 15%
3.6%
8
Nature Communications
4913 papers in training set
Top 44%
2.6%
9
Cell Reports Medicine
140 papers in training set
Top 2%
2.4%
10
Molecular Metabolism
105 papers in training set
Top 0.8%
2.1%
11
eLife
5422 papers in training set
Top 38%
1.9%
12
Hepatology Communications
21 papers in training set
Top 0.2%
1.9%
13
EMBO Molecular Medicine
85 papers in training set
Top 2%
1.7%
14
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
25 papers in training set
Top 0.3%
1.7%
15
Journal of Clinical Investigation
164 papers in training set
Top 4%
1.2%
16
Cell Death & Disease
126 papers in training set
Top 2%
1.1%
17
Frontiers in Immunology
586 papers in training set
Top 6%
1.1%
18
Journal of Experimental Medicine
106 papers in training set
Top 4%
0.7%
19
Disease Models & Mechanisms
119 papers in training set
Top 3%
0.7%
20
Journal for ImmunoTherapy of Cancer
64 papers in training set
Top 1%
0.7%
21
Journal of Neuroinflammation
50 papers in training set
Top 1%
0.7%
22
Development
440 papers in training set
Top 4%
0.7%
23
Biomedicine & Pharmacotherapy
43 papers in training set
Top 1%
0.7%
24
Cell Stem Cell
57 papers in training set
Top 3%
0.6%
25
Stem Cells Translational Medicine
11 papers in training set
Top 0.3%
0.6%